Skip to main content

Recombinant Human ADAMTS5 Protein, CF

R&D Systems, part of Bio-Techne | Catalog # 2198-AD

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
2198-AD-020

Key Product Details

Source

NS0

Accession #

Structure / Form

Recombinant Human ADAMTS5 is prone to proteolytic cleavage at C-terminus. The predominant form of the purified protein lacks the His tag.

Conjugate

Unconjugated

Applications

Enzyme Activity

Product Specifications

Source

Mouse myeloma cell line, NS0-derived human ADAMTS5 protein
Ser262-Pro622, with a C-terminal 10-His tag

Purity

>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Ser262

Predicted Molecular Mass

41 kDa

SDS-PAGE

51 kDa, reducing conditions

Activity

Measured by its ability to cleave the fluorogenic peptide substrate, Abz-TEGEARGSVI-Dap(Dnp)-KK-NH2.
The specific activity is >10 pmol/min/μg, as measured under the described conditions. 

Reviewed Applications

Read 1 review rated 4 using 2198-AD in the following applications:

Formulation, Preparation and Storage

2198-AD
Formulation Lyophilized from a 0.2 μm filtered solution in Sodium Acetate, CaCl2 and NaCl.
Reconstitution
Reconstitute at 200 μg/mL in sterile, deionized water.

Reconstitution Buffer Available:
Size / Price
Qty
Loading...
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -70 °C under sterile conditions after reconstitution.

Background: ADAMTS5

ADAMTS5 (a disintegrin and metalloproteinase with thrombospondin motifs 5), also known as aggrecanase-2 and ADAMTS11, is a member of the family of secreted zinc proteases with a multi-domain structure (1, 2). The protein precursors consist of signal peptide and following domains: pro, catalytic, disintegrin-like, TS type 1 motif, cysteine-rich, spacer and a variable number of TS type 1 motifs. ADAMTS5 is an active protease effectively cleaving alpha2-macroglobulin (3), aggrecan (4), and brevican (5), and is inhibited by TIMP-3 with inhibition constants in the subnanomolar range (6). Based on the murine model studies (7, 8), this protease may be a key enzyme in the degradation of cartilage leading to osteoarthritis and rheumatoid arthritis. The purified rhADAMTS5 starts at the N-terminus of the catalytic domain and ends at the C-terminus of the TSP-1 domain. The amino acid sequence of rhADAMTS5 is 98%, 97%, and 96% identical to that of canine, bovine, and mouse/rat. The aggrecanase activity can be inhibited by 5 mM 1,10-phenanthroline and recombinant human TIMP-3 (Catalog # http://www.rndsystems.com/product_results.aspx?k=973-TM">973-TM).

References

  1. Porter, S. et al. (2005) Biochem. J. 386:15.
  2. Nagase, H. and M. Kashiwagi (2003) Arthritis Res. Ther. 5:94.
  3. Tortorella, M.D. et al. (2004) J. Biol. Chem. 279:17554.
  4. Vankemmelbeke, M.N. et al. (2001) Eur. J. Biochem. 268:1259.
  5. Nakada, M. et al. (2005) Acta Neurophathol (Berl). 110:239.
  6. Kashiwagi, M. et al. (2001) J. Biol. Chem. 276:12501.
  7. Glasson, S.S. et al. (2005) Nature, 434: 644.
  8. Stanton, H. et al. (2005) Nature, 434:648.

Long Name

A Disintegrin-like and Metalloproteinase Domain with Thrombospondin Motifs 5

Alternate Names

ADAMTS11, ADMP-2, Aggrecanase 2

Entrez Gene IDs

11096 (Human); 23794 (Mouse); 304135 (Rat)

Gene Symbol

ADAMTS5

UniProt

Additional ADAMTS5 Products

Product Documents for Recombinant Human ADAMTS5 Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Human ADAMTS5 Protein, CF

For research use only

Loading...
Loading...
Loading...
Loading...